Immuneering Corporation (IMRX) Q1 2024 Earnings
IMRX·Reported May 7, 2024·Before market open
Diluted EPS came in at $-0.49, missed the $-0.45 consensus by $0.04.
Diluted EPS
$-0.49missed by $0.04
Consensus: $-0.45
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Immuneering Corporation's Q1 2024 earnings report.
Immuneering Corporation (IMRX) reported Q1 2024 earnings on May 7, 2024 before market open.
Immuneering Corporation reported diluted EPS of $-0.49 for Q1 2024.
EPS missed the consensus estimate of $-0.45 by $0.04.
You can read the 10-Q periodic report (0001790340-24-000056) directly on SEC EDGAR. The filing index links above go to sec.gov.